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Perioperative (intra- or early postoperative) deaths have been 
reported in cemented total hip arthroplasty (THA) and hemi-
arthroplasty of the hip (Sierra et al. 2009, Talsnes et al. 2013, 
Garland et al. 2017). One reason for early mortality may be 
the so-called Bone Cement Implantation Syndrome (BCIS) 
(Donaldson et al. 2009, Olsen et al. 2014). The symptoms of 
BCIS are hypoxia, with or without hypotension, and/or unex-
pected loss of consciousness occurring at or shortly after the 
time of cementation, mostly in old patients with some comor-
bidity, and may be fatal (Olsen et al. 2014).
Death is undisputedly an important adverse outcome. Thus, 
studying the superior mode of fixation in THA, one should 
also consider short-term and long-term mortality in addition to 
long-term revision rates. However, the complexity of several 
outcomes can make it difficult to conclude which fixation to 
choose for the individual patient scheduled for elective THA. 
We compared perioperative-, short-term, and long-term 
mortality for patients after primary, all-cemented, all-unce-
mented, reverse hybrid (cemented cup and uncemented stem), 
and hybrid (uncemented cup and cemented stem) THAs using 
the Norwegian Arthroplasty Register (NAR). 
Patients and methods
Since its inception in 1987, the NAR has registered informa-
tion on primary THAs and THA revisions in Norway. Among 
the data collected are: the patient’s identity, date of operation, 
indication for THA, type of implants, method of fixation, intra-
operative complications, and other surgery-related factors. In 
addition, patient-related factors like age, sex, and comorbidity 
are collected. The NAR uses the unique identification number 
of each Norwegian to link the primary THA to any subsequent 
Background and purpose — There are reports on peri-
operative deaths in cemented total hip arthroplasty (THA), 
and THA revisions are associated with increased mortal-
ity. We compared perioperative (intraoperatively or within 
3 days of surgery), short-term and long-term mortality after 
all-cemented, all-uncemented, reverse hybrid (cemented cup 
and uncemented stem), and hybrid (uncemented cup and 
cemented stem) THAs.
Patients and methods — We studied THA patients in 
the Norwegian Arthroplasty Register from 2005 to 2018, and 
performed Kaplan–Meier and Cox survival analyses with 
time of death as end-point. Mortality was calculated for all 
patients, and in 3 defined risk groups: high-risk patients (age 
≥ 75 years and ASA > 2), intermediate-risk patients (age ≥ 
75 years or ASA > 2), low-risk patients (age < 75 years and 
ASA ≤ 2). We also calculated mortality in patients with THA 
due to a hip fracture, and in patients with commonly used, 
contemporary, well-documented THAs. Adjustement was 
made for age, sex, ASA class, indication, and year of surgery.
Results — Among the 79,557 included primary THA 
patients, 11,693 (15%) died after 5.8 (0–14) years’ follow-
up. Perioperative deaths were rare (30/105) and found in all 
fixation groups. Perioperative mortality after THA was 4/105 
in low-risk patients, 34/105 in intermediate-risk patients, 
and 190/105 in high-risk patients. High-risk patients had 9 
(CI 1.3–58) times adjusted risk of perioperative death com-
pared with low-risk patients. All 4 modes of fixation had 
similar adjusted 3-day, 30-day, 90-day, 3–30 day, 30–90 day, 
90-day–10-year, and 10-year mortality risk. 
Interpretation — Perioperative, short-term, and long-
term mortality after primary THA were similar, regardless of 
fixation type. Perioperative deaths were rare and associated 
with age and comorbidity, and not type of fixation.
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revisions, and to the National Population Register, which pro-
vides information on death or emigration.  The surgeons fill 
in the register form immediately after surgery and mail it to 
the NAR, where the data are entered electronically (Havelin 
et al. 2000). The data are validated, with 97% completeness 
of reporting of primary THAs, 88% reporting of revisions, 
100% coverage of Norwegian hospitals, and 100% reporting 
of deaths (Furnes et al. 2019). 
We assessed mortality after primary THAs registered with 
complete information on patient characteristics. The NAR 
has registered ASA class since 2005. Therefore, the period 
of inclusion and observation for the present study was from 
January 1, 2005 to December 31, 2018. Patients were included 
with their 1st primary THA only, if they had been subject to 
bilateral primary THA. From 2005 to 2018 the NAR contained 
data on 81,715 primary THA patients, 79,557 were eligible for 
analyses (Figure 1). 
Statistics
We compared patients with cemented, uncemented, reverse 
hybrid or hybrid THAs by Kaplan–Meier (KM) survival anal-
yses. Furthermore, we performed adjusted survival analyses 
using Cox regression models, adjusted for age, sex, ASA class, 
and indication for primary THA. Additionally, we adjusted for 
the year of primary surgery to minimize the effect of time-
dependent confounding.
All patients in each fixation group were followed until 
date of death or emigration, or until December 31, 2018. 
We ignored revisions in the analyses, and estimated adjusted 
hazard rate ratios, as a measure of relative risk, with 95% 
confidence intervals (CI), for modes of fixation and covari-
ates. Primary outcomes were perioperative mortality (intra-
operative death or death within 3 days of THA) and 10-year 
mortality. Secondary outcomes were 30-day, 90-day, 3–30-
day, 30–90-day, 90-day–10-year, and 10-year mortality. 3 
risk groups were assessed: low-risk patients (age < 75 years 
and ASA ≤ 2), intermediate-risk patients (age ≥ 75 years or 
ASA > 2), high-risk patients (age ≥ 75 years and ASA > 2). 
In addition, we assessed 2 subgroups independently of the 
risk groups: (1) patients with THA due to acute or compli-
cations after hip fracture, an emerging indication for THA; 
(2) patients who received commonly used, contemporary, and 
well-documented THAs, comparable to a separate study on 
implant survival, since mortality is being used as a reason 
for choice of fixation principle  (Dale et al. 2019). These two 
latter subgroups were also included in the risk groups. Since 
perioperative deaths were few, comparisons of risk factors 
were also performed by Fisher’s exact test with and without 
Bonferroni multiple comparison correction.
We performed the analyses in concordance with the guide-
lines for statistical analyses of arthroplasty register data 
(Ranstam et al. 2011). The proportional hazard assumptions 
of the Cox survival analyses were largely fulfilled, when 
the smoothed Schoenfeld residuals were visually inspected 
(Figure 2). Competing risk models were not considered, 
since we ignored revision surgery. Bilaterality was not rel-
Figure 1. Flowchart of inclusion and exclusion of total hip arthroplasty (THA) patients. Patients in sub-groups are 





Patients missing information on ASA class
and indication for primary THA
n = 2,158
THA-patients with complete information 
on covariates (n = 79,557):
– cemented, 31,997
– uncemented, 21,553
– reverse hybrid, 23,052
– hybrid, 2,955
Low-risk THA-patients (n = 48,625):
– cemented, 14,348
– uncemented, 16,739
– reverse hybrid, 15,915
– hybrid, 1,622
Patients with THA due to acute or complication
after hip fracture (n = 8,415 a ):
– cemented, 4,339
– uncemented, 1,558
– reverse hybrid, 2,113
– hybrid, 355
Intermediate-risk THA-patients (n = 23,565):
– cemented, 12,960
– uncemented, 3,971
– reverse hybrid, 5,678
– hybrid, 956
Patients with commonly used, contemporary, 
well documented THA (n = 58,777 a ):
– cemented, 23,118
– uncemented, 13,847
– reverse hybrid, 20,125
– hybrid, 1,687
High-risk THA-patients (n = 7,367):
– cemented, 4,689
– uncemented, 842
– reverse hybrid, 1,459
– hybrid, 377
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evant since patients were included only with their 1st pri-
mary THA. 
We considered non-overlapping 95% confidence intervals 
(CI) as statistically significant. The IBM SPSS 24.0 (IB Corp, 
Armonk, NY, USA) and R statistical software (R Centre for 
Statistical Computing, Vienna, Austria) packages were used 
for analyses. The study was performed in accordance with the 
RECORD and STROBE statement.
Ethics, data sharing plan, funding, and potential con-
flicts of interests
The registration of data and the study were performed confi-
dentially on patient consent and according to Norwegian and 
EU data protection rules. Data may be accessible upon appli-
cation to the NAR. The study was fully financed by the NAR, 
and no conflict of interest is declared. 
  
Results
During the study period, 11,693 (15%) of the 79,557 primary 
THA patients died. In general, patients who had cemented 
THA were older and with more comorbidity than those who 
had uncemented THA. Patients receiving reverse hybrid or 
hybrid THAs were intermediate groups concerning age and 
comorbidity. Patients with uncemented, reverse hybrid, and 
hybrid THAs had shorter median follow-up due to increased 
use of these fixation modes towards the end of the study period 
(Tables 1 and 2).
Perioperative mortality
Perioperative deaths were rare (30/105) and found in all modes 
of fixations. Adjusted 3-day mortality risk was similar after 
cemented, uncemented, reverse hybrid, and hybrid THAs 
(Table 3, see Supplementary data). The mortality on the day 
of surgery was 10/105.
THA patients with ASA 3 (few patients with ASA 4), age 
over 75 years, or THA in the course of a hip fracture had a 
higher risk of perioperative death after THA (Table 4). 
When stratified into risk groups, perioperative mortality 
after THA was 4/105 in low-risk patients, 34/105 in intermedi-
ate-risk patients, and 190/105 in high-risk patients. High-risk 
patients had nearly 9 times the risk of adjusted perioperative 
death after primary THA compared with low-risk patients 
(Table 4). We found no statistically significant difference in 
risk of perioperative death between the 4 modes of fixation, in 
either of the 3 risk groups or 2 subgroups (Table 3, see Supple-
mentary data). That was also the finding when assessing peri-
operative death in the 4 fixation groups by Fisher’s exact test 
with Bonferroni multiple comparison correction. In Fisher’s 
exact test without correction, and not adjusted for patient char-
acteristics, uncemented THA had lower perioperative mortal-
ity, compared with cemented (p = 0.03). The 24 patients who 
died were older and more comorbid (Table 5, see Supplemen-
tary data).
Short- and long-term mortality
The 10-year mortality risk and adjusted mortality was simi-
lar regardless of fixation (Table 3, Figure 3). In addition, we 
found similar results for all 4 fixation groups concerning 
30-day, 90-day, 3–30-day, 30–90-day, 90-day–10-year, and 
10-year mortality, and short- and long-term mortality did not 
change throughout the study period. This was also true for the 
finding in the “best-case” group of commonly used, contem-
porary, well-documented THAs.
Discussion
Both the 3-day and the 10-year mortality were similar after all-
cemented, all-uncemented, reverse hybrid, and hybrid THA. 
Risk factors for perioperative death were patient-related and 
Figure 2. The relationship between year postoperatively and the log relative risk (RR) of death for uncemented,  reverse hybrid 
and hybrid THAs, compared with cemented THAs, with 95% confidence intervals. The horizontal green line shows the reference 
relative risk (RR = 1) of cemented THAs. It is adjusted for age, sex, ASA class, indication for primary THA, and year of primary 
THA in the analyses. The course is proportional if lines are parallel.
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not related to mode of fixation. This was also the finding when 
assessing high-risk patients only.
Traditionally, uncemented THAs have had lower implant 
survival than cemented THAs in register studies (Hailer et 
al. 2010, Mäkelä et al. 2014). This was also the case in the 
revision study based on most of the patients included in the 
present study (Dale et al. 2019). Nevertheless, the use of 
uncemented fixation in THA is increasing, even in old and 
frail patients (Troelsen et al. 2013, Mäkelä et al. 2014, Furnes 
et al. 2019). 1 of the explanations for this trend may be the 
fear of sudden perioperative deaths because of 3rd generation 
cementing  technique (pressure cementation) and BCIS. This 
is a well-known complication associated with the use of bone 
cement, but the incidence is low in primary THA (Donaldson 
et al. 2009, Sierra et al. 2009). BCIS have also been high-
lighted in papers on cemented hemiarthroplasty used in old 
and frail femoral neck fracture patients (Talsnes et al. 2013, 
Olsen et al. 2014, Rutter et al. 2014).
Acknowledging the existence of BCIS, and that modern 
intensive care medicine can successfully treat the acute and 
potentially fatal BCIS, we considered deaths within 3 days 
postoperatively as potentially associated with the cementa-
tion, although other causes of death were also possible as a 
result of the surgical trauma. 
Information on the cause of death was not available in our 
patients. Sierra et al. (2009) reported 3/10,000 perioperative 
Table 1. Demographic risk factors by type of fixation
 Number of Dead Cemented Uncemented Reverse Hybrid
  THA patients patients (%) THA (%) THA (%) hybrid THA (%) THA (%)
Risk factors n = 79,557 n = 11,693 a n = 31,997 n = 21,553 n = 23,052 n = 2,955
Sex
 Male 28,512 4,450 (16) 31 42 38 36
  Female 51,052 7,243 (14) 69 58 62 64
Age  
 < 45 2,843 57 (2) 1 8 3 2
  45–54 6,874 209 (3) 2 17 10 7
  55–64 18,876 1,122 (6) 14 32 30 22
  65–74 28,235 3,277 (12) 39 30 36 33
  75–84 19,156 5,283 (28) 37 11 17 30
  ≥ 85 3,573 1,745 (49) 7 1 3 6
ASA class
 1 16,063 1,281 (8) 15 27 21 15
 2 47,899 5,761 (12) 59 59 62 63
 3 15,247 4,465 (29) 25 17 17 21
 4 348 195 (56) 1 0.3 0.3 1
Indication for primary THA 
 Osteoarthritis 59,285 8,015 (14) 76 71 77 67
 Inflammatory hip disease 1,722 269 (16) 2 2 2 2
 Acute hip fracture 3,187 661 (21) 5 2 4 5
  Complication after
    hip fracture 5,208 1,735 (33) 8 5 5 7
     childhood hip disease 7,266 394 (5) 4 16 8 15
  Osteonecrosis of the 
    femoral head 2,268 442 (19) 3 3 3 3
  Other diagnosis 621 177 (29) 1 1 1 1
 
a Dead overall 15%
Table 2. Main characteristics of the included THA patients by types of fixation
    Reverse
  All Cemented Uncemented hybrid Hybrid
 n = 79,557 n = 31,997 n = 21,553 n = 23,052 n = 2,955
Dead at 10 years, n (%) 10,330 (13) 6,843 (21) 1,260 (6) 2,018 (9) 209 (7)
Mean follow-up (range), years 5.8 (0–14)  6.9 (0–14) 4.9 (0–14) 5.5 (0–14) 3.8 (0–14)
Median follow-up (IQR), years 5.4 (2.6–8.8) 7.0 (3.4–10) 4.2 (1.8–7.6) 5.2 (2.9–7.7) 2.6 (1.1–4.9)
Mean age (range) 69 (11–97) 73 (22–98)  62 (11–95) 66 (14–97) 70 (17–97)
Mean ASA-class 2.0 2.1 1.9 2.0 2.1
At risk after 10 years 13,924 8,811 2,387 2,402 324
IQR = Inter quartile range
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deaths after cemented THA on the day of surgery, which was 
higher than our finding (1/10,000).  Pripp et al. (2014) found 
that only half of the deaths on the day of cemented arthro-
plasty might be attributed to BCIS. A study from the Finnish 
Hospital Discharge register found similar 2-day mortality for 
patients after cemented, uncemented, and hybrid THA (Ekman 
et al. 2019). A Swedish study reported a small, but statistically 
significant increased relative risk of death in patients during 
the first 14 days after cemented THA, compared with unce-
mented THA (Garland et al. 2017). We did not find such a 
difference, even in the high-risk subgroup or in the group of 
patients with THA in the course of a hip fracture. However, we 
adjusted for comorbidity by ASA class, whereas Garland et 
al. adjusted by modified Charlson Comorbidity Index, which 
may have slightly different effect (Lavelle et al. 2015).
The potential risk of perioperative death needs to be 
weighed against other outcomes, such as the risk of revision 
due to fracture, dislocation, and infection. Revision risk due 
to these causes is higher after uncemented THAs (Hailer et al. 
2010, Stea et al. 2014, Dale et al. 2019). Such complications 
may implicate a poorer functional outcome, increased morbid-
ity, and long-term mortality (Lindahl et al. 2007, Gundtoft et 
al. 2017, Cnudde et al. 2019). 
In the subgroup of commonly used, contemporary, well-
documented THAs, the differences in risk of revision between 
the 4 modes of fixation, presented in a separate paper, were 
quite small (Dale et al. 2019). The exception was that unce-
mented THA in females over 55 years of age had a higher risk 
of revision due to aseptic loosening, periprosthetic fracture, 
and dislocation. Patients may have increased long-term mor-
tality after such revisions (Gundtoft et al. 2017, Cnudde et al. 
2019). 3-day and 10-year mortality was similar for all fixa-
tions in our study, indicating that perioperative-, short-term, or 
long-term mortality risk should not dictate what fixation prin-
ciple to choose in primary THA, even in high-risk patients. 
Mortality is low in healthy old patients elected for THA (Lie 
et al. 2000, Jamsen et al. 2013). We found a 10-year mortality 
of 15–16% for all modes of fixation, and 7–8% in the low-risk 
class. However, Lie et al. (2010) found an excess mortality 
of 0.12% in the first 26 days after primary THA compared 
with the baseline mortality for these patients. From 70 days 
and onwards THA patients have been reported to have lower 
mortality compared with the baseline population (Lie et al. 
2002). Hunt et al. (2013) reported a yearly decreasing 90-days 
mortality after contemporary THA in the National Joint Reg-
istry for England and Wales between 2003 and 2011, and simi-
lar results concerning 90-days mortality after all 4 modes of 
fixation. The decreased mortality was attributed to improved 
perioperative prophylaxis and treatment. We did not find a 
similar decrease in mortality, but several of the modifiable 
factors suggested, such as chemical thromboembolic prophy-
laxis and spinal anesthesia, were used in the vast majority of 
THAs in Norway during the study period. Mortality from 30 
days after primary THA, regardless of mode of fixation, has 
been found to be lower than for controls (matched popula-
Figure 3. Patient survival curve for the 4 modes of fixation adjusted for 
age, sex, ASA class, indication for primary THA, and year of primary 
surgery.
Table 4. Risk factors of perioperative death. Adjusted for age, sex, 
ASA class, indication for primary THA, and year of primary surgery
  Deaths 3-day relative
  within mortality
Risk factor  THAs 3 days risk (CI)
Sex
 Female 51,045 18 1
  Male 28,512 6 0.7 (0.3–1.9)
ASA class  
 1 16,063 0  
 2 47,899 8 1
  3 15,247 15 3.2 (1.3–7.7)
  4 348 1 5.2 (0.6–45)
Age group 
 < 45 years 2,843 0  
  45–54 6,874 0  
  55–64 18,876 1 0.6 (0.1–5.6)
  65–74 28,235 3 1
  75–84 19,156 12 4.4 (1.2–16)
  ≥ 85 3,573 8 9.4 (2.4–37)
Indication for primary THA 
 Osteoarthritis 59,285 10 1
 Inflammatory hip disease 1,722 0  
 Acute hip fractures  3,187 5 9.4 (3.1–28)
  Complication after 
    hip fracture 5,208 6 3.1 (1.1–8.7)
    childhood hip disease 7,266 1 2.8 (0.4–22)
  Osteonecrosis of the 
    femoral head 2,268 1 2.4 (0.3–19)
  Other diagnosis 621 1 7.2 (0.9–59)
Risk class a 
 Low 48,625 2 1
  Intermediate 23,565 8 2.7 (0.4–16)
  High 7,353 14 8.7 (1.3–58)
a Adjusted for age, sex, indication for primary THA, and year of 
  primary surgery.
  Low = age < 75 years and ASA ≤ 2
  Intermediate = age ≥ 75 years or ASA > 2
  High = age ≥ 75 years and ASA > 2
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tion without THA) (Pedersen et al. 2011, Garland et al. 2017). 
Either patients chosen for elective THA are healthier than the 
average population, or one may say that successful THA may 
protect the patients and result in lower mortality than the cor-
responding population (Cnudde et al. 2018). Probably very 
frail patients are not selected for elective THA. 
Strengths and limitations
Our study is based on validated data from the NAR, with 
high completeness of reporting of primary THAs and deaths 
(Furnes et al. 2019). We therefore had the benefit of complete 
information on patient-related risk factors.  Accordingly, we 
were able to adjust for important differences between the 
patient groups. Risk factors we included in the analyses such 
as age, ASA class, and indication for primary THA are associ-
ated with adverse outcomes and mortality after surgery (Bel-
mont et al. 2014, Cnudde et al. 2018). The effect of adjustment 
for such risk factors on 10-year KM survival after cemented 
THA illustrates the importance including age and comorbidi-
ties in assessments of mortality. 
Perioperative deaths are rare, and it may only be possible 
to study these in large databases such as arthroplasty regis-
ters. We included a large number of THAs with exact survival 
times of the patients. Since results are from a nationwide THA 
population, external validity should be good. 
Register studies have inherent limitations (Varnum et al. 
2019). A limitation in our study was the limited information 
on the cause of perioperative death. We therefore considered 
deaths within 3 days postoperatively as potentially associ-
ated with the cementation. This was an approximation, and 
Pripp et al. (2014) found that only half of perioperative mor-
talities are attributed to BCIS. This indicates that the number 
of perioperative deaths caused by BCIS in our study would 
be even lower for THAs involving bone cement. In Finland, 
where uncemented THA is more common, even in old and 
frail patients, similar perioperative mortality has been reported 
after cemented and uncemented THAs (Ekman et al. 2019).
The follow-up is relatively short and different for the 4 fixa-
tion groups, since there has been a shift towards more use of 
uncemented, reverse hybrid and hybrid THAs (see Table 2) 
(Furnes et al. 2019). We did not find differences in periopera-
tive, short-, or long-term mortality. Limited follow-up should 
therefore have a small effect, if any, on the results. 
Conclusion
Results after contemporary primary THA may be good regard-
less of fixation, but uncemented THA had an increased risk 
of revision in  a cohort of patients also included in the pres-
ent study (Dale et al. 2019).  Perioperative deaths, however, 
were associated only with patient-related risk factors, like age 
and comorbidity, and not surgery-related factors like fixation. 
Sudden death will be the most serious adverse event, but death 
during a course of complications is equally serious. We found 
that perioperative, short-term, and long-term mortality after 
primary THA were similar, regardless of fixation mode. Use of 
bone cement appears to be safe in all patient groups. Periopera-
tive deaths were associated with advanced age and comorbid-
ity, and not type of fixation, and should therefore not guide the 
choice of fixation in primary THA, even in high-risk patients. 
Supplementary data
Tables 3 and 5 are available as supplementary data in the online 
version of this article, http://dx.doi.org/10.1080/17453674. 
2019.1701312
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